AnchorDx

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Hedera Dx

This company develops blood-based liquid biopsy tests and software for hospital laboratories to perform in-house molecular cancer diagnostics for patients.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Amadix

This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.

Naveris

This molecular diagnostics company develops and commercialises liquid biopsy tests for the early detection and clinical management of viral-associated cancers for healthcare providers.

Epigenomics

This molecular diagnostics company develops blood-based liquid biopsy tests for the early detection and screening of cancer for healthcare providers and clinical laboratories.

Guardant

The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.